Featured
Interactive tools
Interactive data visualizations of antibiotic use and resistance in North America and Europe
Narrow your search further by selecting options from the drop down menus below.
|
Title |
Date | Description | |
|---|---|---|---|
|
|
March 2009 | ||
|
|
June 2001 |
Incorporating fitness cost of resistance into the model, what is the optimal use of antibiotics differing in resistance levels? And what is effect of the nonconvexities in antibiotic treatment costs on the optimal antibiotic use strategy?
|
|
|
|
August 2010 |
Could a neglected technology turn out to be an important mechanism against antibiotic resistance?
|
|
|
|
December 2002 | ||
|
|
September 09, 2008 |
Is a national policy of multiple first-line therapies (MFTs) more effective than single first-line therapies or cycling for controlling malaria?
|
|
|
|
October 2000 | ||
|
|
August 2007 | ||
|
|
April 2012 |
What are the factors that make drug resistance a more difficult problem for poorer countries?
|
|
|
|
February 2013 |
How has the epidemiology of methicillin-resistant Staphylococcus aureus (MRSA) changed in recent years?
|
|
|
|
May 2009 |
How should the Indian health system reform to attain levels of health similar to those in other progressive democracies?
|